Zenotech [ZENOTECH] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Zenotech Laboratories Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Zenotech Laboratories Ltd. wins in 6 metrics, Divi's Laboratories Ltd. wins in 12 metrics, with 1 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Zenotech Laboratories Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 82.73 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 2.82 10.82 Zenotech Laboratories Ltd.
Debt-to-Equity Ratio 0.00 0.58 Tie
PEG Ratio 5.79 4.63 Divi's Laboratories Ltd.
EV/EBITDA 18.68 48.63 Zenotech Laboratories Ltd.
Profit Margin (TTM) 8.02% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 20.84% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 20.84% 29.65% Divi's Laboratories Ltd.
Return on Equity 5.84% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 5.06% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $56.25M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -29.00% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 6.62 16.18 Zenotech Laboratories Ltd.
Enterprise Value $2.50B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 5.97 15.86 Zenotech Laboratories Ltd.
Gross Profit Margin (TTM) 100.00% 63.71% Zenotech Laboratories Ltd.
Revenue per Share (TTM) $7 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $0.55 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.09 0.19 Zenotech Laboratories Ltd.

Zenotech Laboratories Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

ZENOTECH
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Zenotech Laboratories Ltd.0.13%-1.28%1.39%-1.00%-8.38%-3.38%
Divi's Laboratories Ltd.0.67%-3.26%-1.31%2.02%1.80%2.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Zenotech Laboratories Ltd.-29.00%-15.94%2.47%2.12%-12.79%-25.87%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Zenotech Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricZENOTECHDIVISLAB
Market Information
Market Cap i₹2.78B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i7,881253,443
90 Day Avg. Volume i17,746283,911
Last Close₹44.69₹6,576.50
52 Week Range₹33.55 - ₹67.00₹5,636.50 - ₹7,071.50
% from 52W High-33.30%-7.00%
All-Time High₹173.59 (Oct 01, 2007)₹7,071.50 (Jul 08, 2025)
% from All-Time High-74.26%-7.00%
Growth Metrics
Quarterly Revenue Growth0.16%0.12%
Quarterly Earnings Growth0.14%-0.01%
Financial Health
Profit Margin (TTM) i0.08%0.24%
Operating Margin (TTM) i0.21%0.30%
Return on Equity (TTM) i0.06%0.15%
Debt to Equity (MRQ) i0.000.58
Cash & Liquidity
Book Value per Share (MRQ)₹16.11₹580.95
Cash per Share (MRQ)₹5.27₹122.95
Operating Cash Flow (TTM) i₹69.82M₹19.67B
Levered Free Cash Flow (TTM) i₹56.13M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Zenotech Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricZENOTECH (Apr 26, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i82.7367.11
Forward P/E iN/A53.75
PEG Ratio i5.794.63
Price to Sales (TTM) i6.6216.18
Price to Book (MRQ) i2.8210.82
Market Capitalization
Market Capitalization i₹2.78B₹1.69T
Enterprise Value i₹2.50B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i5.9715.86
Enterprise to EBITDA i18.6848.63
Risk & Other Metrics
Beta i0.090.19
Book Value per Share (MRQ) i₹16.11₹580.95

Financial Statements Comparison: Zenotech Laboratories Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricZENOTECH (2025)DIVISLAB (2025)
Revenue/Sales i389.76M93.25B
Cost of Goods Sold i52.64M38.70B
COGS % of Revenue i13.5%41.5%
Gross Profit i337.11M54.55B
Gross Margin i86.5%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i31.79M25.71B
Operating Margin i8.2%27.6%
EBITDA i157.24M33.19B
EBITDA Margin i40.3%35.6%
Pre-Tax Income i106.92M29.16B
Pre-Tax Income % of Revenue i27.4%31.3%
Income Tax i50.79M7.25B
Income Tax % of Revenue i13.0%7.8%
Net Income (Profit) i56.13M21.91B
Profit Margin i14.4%23.5%

Balance Sheet & Liquidity Metrics

MetricZENOTECH (2025)DIVISLAB (2025)
Cash & Equivalents i265.75M4.15B
Total Current Assets i359.89M100.81B
Total Current Assets % of Revenue i92.3%108.1%
Total Current Liabilities i125.87M14.52B
Total Current Liabilities % of Revenue i32.3%15.6%
Long-Term Debt i020.00M
Long-Term Debt % of Revenue i0.0%0.0%
Total Shareholders Equity i961.31M149.69B
Retained Earnings i-1.74B134.00B
Retained Earnings % of Revenue i-447.6%143.7%
Property, Plant & Equipment i22.30M3.19B

Cash Flow Statement Comparison

MetricZENOTECH (2025)DIVISLAB (2025)
Operating Cash Flow i69.82M19.67B
Operating Cash Flow % of Revenue i17.9%21.1%
Capital Expenditures i-38.63M-14.38B
Free Cash Flow i56.25M2.15B
FCF Margin i14.4%2.3%
Debt Repayment i0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricZENOTECHDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i61.03M265.47M
Float Shares i11.70M117.72M
% Held by Insiders i84.53%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i15.47%19.31%

Dividend Analysis & Yield Comparison: Zenotech Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricZENOTECHDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025